Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating two digital mindfulness meditation programs to support mental health and well-being in younger breast cancer survivors who have elevated depressive symptoms. This phase III trial focuses on women diagnosed with breast cancer at age 50 or younger who have completed their main cancer treatments at least six months ago. The study aims to compare a live, instructor-led online program to a self-paced app-based program and also to explore factors that might influence how well these interventions work, including psychological distress levels and social factors like race and education. Participants will be assigned to one of three groups: a live online Mindful Awareness Practices (MAPs) program delivered over Zoom, a self-paced MAPs digital app, or a meditation-only control group. The live online program includes guided meditations, exercises to manage pain and emotions, and cultivating kindness, with daily home practice increasing from 5 to 20 minutes. The app program unlocks lessons sequentially as participants progress. Meditation use will be tracked across all groups to measure engagement. During the study, participants will report depressive symptoms two weeks after completing the intervention. Researchers will also collect information on emotion regulation strategies and social determinants of health, and monitor how much participants practice mindfulness to understand the programs' effects. The total intervention lasts six weeks, and participants must be able to use a digital device and communicate in English or Spanish. Safety and participation are closely monitored throughout the study.
Actively Recruiting
Researchers are evaluating a phase III trial to compare a text-based smoking cessation intervention with a printed manual to help rural cancer survivors who smoke quit smoking. The study focuses on patients diagnosed with cancer in the past 10 years who currently smoke at least five cigarettes daily and live in rural areas. The trial aims to assess the effectiveness of a scheduled gradual reduction program paired with support messages versus an informational booklet for quitting smoking. Participants are randomly assigned to one of two groups. One group follows an eight-week personalized schedule to gradually reduce cigarette use and receives cessation support messages via text for 12 weeks. The other group receives the National Cancer Institute's Clearing the Air booklet to guide gradual quitting. After completing the intervention, patients are followed up at six months to evaluate outcomes. During the study, participants complete questionnaires and provide urine samples to biochemically validate smoking cessation. Researchers measure smoking cessation success up to six months after the quit date and assess quality of life at 30 days and six months post-quit. The study includes ongoing monitoring through text messages and patient-completed measures, ensuring comprehensive data collection over the follow-up period.